Literature DB >> 23609794

Functional impairment in alcoholic liver disease and non-alcoholic fatty liver disease is significant and persists over 3 years of follow-up.

Chris Elliott1, James Frith, Christopher P Day, David E J Jones, Julia L Newton.   

Abstract

BACKGROUND AND AIMS: Alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) are common and increasing in prevalence. We examined prevalence and predictors of functional impairment in biopsy-proven ALD and NAFLD. Change in function over 3 years was explored.
METHODS: Validated functional, cognitive, autonomic, and fatigue symptom assessment tools were completed by patients who had attended our liver clinic.
RESULTS: Totals of 224 NAFLD and 107 ALD patients returned the assessment tools. NAFLD and ALD demonstrated comparable functional difficulties, which were significantly worse than controls (p < 0.001) with the proportion of participants experiencing difficulty significantly higher [x (2) 8.93(3), (p = 0.01)]. No significant functional difficulty was demonstrated between those participants who were pre-cirrhotic or cirrhotic. Independent associations were present between difficulty with function in ALD and higher burden of autonomic and cognitive symptoms (p = 0.02) and in NAFLD-increased cognitive difficulty (p < 0.0001), age (p = 0.001), fatigue (p = 0.01), lower albumin (p = 0.02), and bilirubin (p = 0.04). PHAQ scores increased 21 % 2008-2011 {(3.2/15.6) [15.6 (0-93.8)] to 18.75 (0-90.6)}. Functional difficulty of participants alive [15.6 (0-96.9)] was significantly less compared to those who died [40.6 (0-100)] (p = 0.02).
CONCLUSIONS: NAFLD and ALD patients experience significant functional impairment affecting activities of daily living that persists over time. This has implications for the management of liver disease and service provision.

Entities:  

Mesh:

Year:  2013        PMID: 23609794     DOI: 10.1007/s10620-013-2657-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Burden of liver disease in the United States: summary of a workshop.

Authors:  W Ray Kim; Robert S Brown; Norah A Terrault; Hashem El-Serag
Journal:  Hepatology       Date:  2002-07       Impact factor: 17.425

Review 2.  Alcoholic liver disease.

Authors:  Robert S O'Shea; Srinivasan Dasarathy; Arthur J McCullough
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

3.  Autonomic dysfunction: often present but usually ignored in patients with liver disease.

Authors:  Francesco Salerno; Massimo Cazzaniga
Journal:  Liver Int       Date:  2009-11       Impact factor: 5.828

4.  Prevalence of and risk factors for hepatic steatosis in Northern Italy.

Authors:  S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli
Journal:  Ann Intern Med       Date:  2000-01-18       Impact factor: 25.391

5.  Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease.

Authors:  Julia L Newton; Jessie Pairman; Katharine Wilton; David E J Jones; Christopher Day
Journal:  Clin Auton Res       Date:  2009-12       Impact factor: 4.435

6.  Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance.

Authors:  J L Newton; D E J Jones; E Henderson; L Kane; K Wilton; A D Burt; C P Day
Journal:  Gut       Date:  2008-02-12       Impact factor: 23.059

7.  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.

Authors:  M W Johns
Journal:  Sleep       Date:  1991-12       Impact factor: 5.849

8.  Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease.

Authors:  James Frith; Christopher P Day; Lisa Robinson; Chris Elliott; David E J Jones; Julia L Newton
Journal:  J Hepatol       Date:  2009-10-23       Impact factor: 25.083

Review 9.  Autonomic dysfunction in chronic liver disease.

Authors:  James Frith; Julia L Newton
Journal:  Liver Int       Date:  2009-04       Impact factor: 5.828

10.  Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

Authors:  J D Fisk; P G Ritvo; L Ross; D A Haase; T J Marrie; W F Schlech
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

View more
  19 in total

Review 1.  Exercising the hepatobiliary-gut axis. The impact of physical activity performance.

Authors:  Emilio Molina-Molina; Raquel Lunardi Baccetto; David Q-H Wang; Ornella de Bari; Marcin Krawczyk; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2018-06-14       Impact factor: 4.686

2.  Non-alcoholic Fatty Liver Disease: Also a Disease of the Brain? A Systematic Review of the Preclinical Evidence.

Authors:  Anne Catrine Daugaard Mikkelsen; Kristoffer Kjærgaard; Rajeshwar Prosad Mookerjee; Hendrik Vilstrup; Gregers Wegener; Cecilie Bay-Richter; Karen Louise Thomsen
Journal:  Neurochem Res       Date:  2022-03-01       Impact factor: 3.996

3.  Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo.

Authors:  Leon M Tai; Kevin P Koster; Jia Luo; Sue H Lee; Yue-Ting Wang; Nicole C Collins; Manel Ben Aissa; Gregory R J Thatcher; Mary Jo LaDu
Journal:  J Biol Chem       Date:  2014-09-12       Impact factor: 5.157

Review 4.  Economic and Quality-of-Life Implications of Non-Alcoholic Fatty Liver Disease.

Authors:  Zobair M Younossi; Linda Henry
Journal:  Pharmacoeconomics       Date:  2015-12       Impact factor: 4.981

5.  The effects of cystatin C and alkaline phosphatase changes on cognitive function 12-months after bariatric surgery.

Authors:  Michael L Alosco; Mary Beth Spitznagel; Gladys Strain; Michael Devlin; Ronald Cohen; Ross D Crosby; James E Mitchell; John Gunstad
Journal:  J Neurol Sci       Date:  2014-07-22       Impact factor: 3.181

6.  Associations between nut intake, cognitive function and non-alcoholic fatty liver disease (NAFLD) in older adults in the United States: NHANES 2011-14.

Authors:  Sze-Yen Tan; Ekavi N Georgousopoulou; Barbara R Cardoso; Robin M Daly; Elena S George
Journal:  BMC Geriatr       Date:  2021-05-17       Impact factor: 3.921

Review 7.  Fatigue in chronic liver disease patients: prevalence, pathophysiology, and management.

Authors:  Artur Kośnik; Maciej Wójcicki
Journal:  Prz Gastroenterol       Date:  2022-03-18

8.  Protective Effects of Luteolin on Lipopolysaccharide-Induced Acute Renal Injury in Mice.

Authors:  Shao-Bin Xin; Hao Yan; Jing Ma; Qiang Sun; Li Shen
Journal:  Med Sci Monit       Date:  2016-12-28

9.  Health-related quality of life and patient-reported outcome measures in NASH-related cirrhosis.

Authors:  Lorraine McSweeney; Matthew Breckons; Gulnar Fattakhova; Yemi Oluboyede; Luke Vale; Laura Ternent; Maria-Magdalena Balp; Lynda Doward; Clifford A Brass; Fiona Beyer; Arun Sanyal; Quentin M Anstee
Journal:  JHEP Rep       Date:  2020-03-06

10.  Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction.

Authors:  Ying Shang; Patrik Nasr; Mattias Ekstedt; Linnea Widman; Per Stål; Rolf Hultcrantz; Stergios Kechagias; Hannes Hagström
Journal:  JHEP Rep       Date:  2020-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.